Office of Health Economics2d
Challenges and Solutions for Budget Impact Analysis of Gene Therapies
Existing horizon scanning activities could be strengthened to aid budget planning in the context of high upfront cost therapies such as gene therapies. International collaborations could be leveraged ...
Office of Health Economics8d
OHE to host the Health Economists’ Study Group Summer 2025
The Office of Health Economics is delighted to host the Health Economists’ Study Group Summer Meeting, which will run from 30th June – 2nd July 2025. Founded in 1972, the Health Economists’ Study ...
Office of Health Economics14d
Advancing Rare Disease Care: Challenges and Key Issues
The policy environment for rare disease and orphan medicines is complex and encompasses regulation, reimbursement, and ...
OHE15d
EQ-5D and beyond: OHE’s contributions to EuroQol research and meetings
Measuring and valuing health outcomes is arguably what makes health economics such a unique and sometimes controversial discipline. The idea of putting a numerical value on an individual’s health ...
OHE20d
Hannah Hussain
Hannah joined OHE as an Economist in September 2024. She holds an MPharm degree from the University of Nottingham and an MSc in Health Economics and Health Policy from the University of Birmingham. As ...
OHE27d
Mike Drummond
Michael Drummond is Professor Emeritus and former Director of the Centre for Health Economics at the University of York in the United Kingdom. His main field of interest is in the economic evaluation ...
OHE21d
Dr. Seán Byrne
Dr Seán Byrne is Senior Manager, Legal & Regulatory Affairs for the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Seán represents EUCOPE members at relevant European Medicines ...
OHE25d
Stuart Carroll
Stuart Carroll is a senior health economist and epidemiologist with over 18 years of experience, specialising in infectious diseases and vaccines, market access, health technology appraisal, public ...
OHE19d
Dimitrios Kourouklis
Dimitrios is an economist and his research interests lie in the fields of the economics of innovation and specifically on the economics of pharmaceutical markets and R&D. In addition, he is interested ...
OHE20d
Dr. Inmaculada Hernandez
Dr. Inmaculada (Inma) Hernandez is a Professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Hernandez is a pharmacist and a scholar whose ...
OHE23d
Luigi Siciliani
Luigi Siciliani is a Professor of Health Economics at the Department of Economics and Related Studies at the University of York, where he directs the MSc in Health Economics. He is currently an Editor ...